Clinical Diagnostics Market
Covid-19 impact:Clinical Oncology NGS Market Is Expected At A CAGR Of 13.2% 2025 | 7/29/2020
… accelerate the growth of NGS technology in clinical diagnostics. Owing to the fact that next generation sequencing offers several advantages such as sensitivity, accuracy, and speed, this technology is anticipated to drive the oncology clinical diagnostics market . Furthermore, next generation sequencing aids in the assessment of multiple genes in a single assay, thereby eliminating the need to order several tests for determination of underlying mutation. North America held the dominant …
… View the full release here: https://www.businesswire.com/news/home/20200716005647/en/ Industry Insights on Market Expansion into the US HbA1c Testing Market (Graphic: Business Wire) In a span of six-weeks the client, a clinical diagnostics market player based out of APAC successfully actioned their market expansion plan in point-of-care testing for the HbA1c market in the United States and recorded substantial revenue growth using a highly targeted …
… Market Forecast by Value 3.4 Global Multiplex Assays Market by Application 3.4.1 Global Multiplex Assays Research & Development Market by Value 3.4.2 Global Multiplex Assays Research & Development Market Forecast by Value 3.4.3 Global Multiplex Assays Clinical Diagnostics Market by Value 3.4.4 Global Multiplex Assays Clinical Diagnostics Market Forecast by Value 3.4.5 Global Multiplex Assays Companion Diagnostics Market by Value 3.4.6 Global Multiplex Assays Companion Diagnostics Market Forecast by Value 3.5 Global …
Global Automated and Rapid Microbiological Tests Industry | 7/14/2020
Global Automated and Rapid Microbiological Tests Industry By Reportlinker Read the full report: https://www.reportlinker.com/p04707098/?utm_source=PRN Amid the COVID-19 crisis, the global market for Automated and Rapid Microbiological Tests estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$7.8 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027.GC/CRT (Clinical), one …
New York, April 16, 2020 (GLOBE NEWSWIRE) – Reportlinker.com announces the release of the report “Global Clinical Diagnostics Market, By Type of Test, By Product, By Application, By Region, Competition, Forecast & Opportunities, 2025” - https://www.reportlinker.com/p05885388/?utm_source=GNW Clinical diagnostics includes medical tests that are performed in a pathology or a diagnostic center or hospital or any other medical facility to diagnose or detect any disease or any other medical …
Bio-Rad Launches Serology Test to Detect Coronavirus Antibody - April 9, 2020 - Zacks.com | 4/9/2020
… company intends to use the FDA’s Emergency Use Authorization (“EUA”) to speed up the availability of the kit in the United States. With the launch, Bio-Rad aims to strengthen its position in the Clinical Diagnostics market globally. Significance of the Launch The human body’s antigen production is stimulated by the viral antigens to fight after being infected by the SARS-CoV-2. Per the company, the kit will enable …
Hospitals to Dominate Clinical Diagnostics Market Segment During Forecast Period | 3/24/2020
Increasing adoption of point of care testing is expected to drive growth of global clinical diagnostics market Clinical Diagnostics Market Type of Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Software & Services), By Application (Infectious Diseases (Sepsis, Respiratory Diseases, Gastrointestinal Diseases, Nephrological Diseases, New Corona Virus (COVID-19), AIDS & Hepatitis), Antimicrobial Resistance & Health Associated Infections (Antimicrobial …
pramod posted a blog post | 3/13/2020
Increasing adoption of point of care testing is expected to drive growth of global clinical diagnostics market According to TechSci Research report, “ Global Clinical Diagnostics Market Type of Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Software & Services), By Technique (Immunodiagnostics (ELISA, Western Blot, Radioimmunoassay, Hematology, Others), Molecular Diagnostics (PCR, Microarrays, Hybridization, DNA Diagnostics, Others), Microbiology …
Clinical Diagnostics Market Scope, Size, Share, Growth, Trend and Forecast by 2025 | 3/13/2020
by mack nene TechSci Research Increasing adoption of point of care testing is expected to drive growth of global clinical diagnostics market According to TechSci Research report, “ Global Clinical Diagnostics Market Type of Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Software & Services), By Technique (Immunodiagnostics (ELISA, Western Blot, Radioimmunoassay, Hematology, Others), Molecular Diagnostics (PCR, Microarrays …
… by the growing obese population base and sedentary lifestyles Key Topics Covered Chapter 1 Methodology and Scope Chapter 2. Executive Summary Chapter 3. Biomarkers Market Variables, Trends & Scope 3.1. Biomarkers Market Lineage Outlook 3.1.1. Clinical Diagnostics Market Outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Regulatory Framework 3.3.1. Reimbursement Framework 3.3.2. Standards & Compliances 3.4. Market Dynamics 3.4.1. Market Driver Analysis 3.4.1.1. Increasing Prevalence of Chronic Diseases 3.4.1.2. Technological Advancements 3.4.1.3. Funding …
SQI Diagnostics to Announce Fourth Quarter and Fiscal 2019 Results | PR Newswire | 12/4/2019
… 277 About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human …
The “Clinical Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)” report has been added to ResearchAndMarkets.com’s offering. The clinical diagnostics market is driven by factors such as the growing incidence of infectious and chronic diseases, and increasing adoption of the automated platform. Infectious and chronic diseases are considered the leading causes of death, worldwide. According to the World Health Organization, lower respiratory infections remained the most deadly communicable diseases that …
DUBLIN–(BUSINESS WIRE)–Nov 28, 2019– The “Clinical Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)” report has been added to ResearchAndMarkets.com ‘s offering. The clinical diagnostics market is driven by factors such as the growing incidence of infectious and chronic diseases, and increasing adoption of the automated platform. Infectious and chronic diseases are considered the leading causes of death, worldwide. According to the World Health Organization, lower respiratory infections …
Global Clinical Diagnostics Market: Growth, Trends and Forecasts (2019-2024) - ResearchAndMarkets.com Associated Press from “health trends” - Google News https://ift.tt/2XVu8jz via IFTTT …
(USA-CA-San Diego) Sales Representative - Western Region | 10/19/2019
… adhere to business needs and objectives set annually by Sales Management and will include territory routing, call activity and pre-call planning goals. · Collaborate with sales representatives and leaders within the larger Eurofins U.S. Clinical Diagnostics market on strategic cross-selling initiatives Selling: ·Develop and implement a territory and strategic sales plan involving multiple stakeholders in the growth of the blood test. ·Maintain and grow the base revenue stream and …
Global Gonorrhea Diagnostics Industry Market Research Report | 10/17/2019
… Status and SWOT Analysis 7.7 South America Gonorrhea Diagnostics Market Status and SWOT Analysis 8 Competitive Landscape 8.2.2 Gonorrhea Diagnostics Product Introduction 8.2.3 Ortho Clinical Diagnostics Production, Value ($), Price, Gross Margin 2014-2019 8.2.4 Ortho Clinical Diagnostics Market Share of Gonorrhea Diagnostics Segmented by Region in 2018 8.3 Lonza 8.3.2 Gonorrhea Diagnostics Product Introduction 8.3.3 Lonza Production, Value ($), Price, Gross Margin 2014-2019 8.3.4 Lonza Market Share of Gonorrhea Diagnostics Segmented by …
Richard Creager Joins Ubiquitome Board of Directors | PR Newswire | 8/29/2019
… Creager received his PhD in Microbiology from the University of Pittsburgh School of Medicine. Paul Pickering , Ubiquitome CEO said, “Richard has a wealth of experience in developing successful products, systems and companies in the clinical diagnostics market . We are delighted to welcome his expertise to the Ubiquitome board as we seek to realize the potential of our mobile technologies for the benefit of patients around the world.” Fellow board member …
SQI Diagnostics Reports Third Quarter 2019 Results | PR Newswire | 8/28/2019
… sqidiagnostics.com About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human …
SQI Diagnostics to Announce Third Quarter 2019 Results | PR Newswire | 8/20/2019
… sqidiagnostics.com About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human …
ABT or BIO: Which Stock Has Better Potential Right Now? - Nasdaq.com | 7/15/2019
… rising incidence of chronic diseases, increasing occurrence of infectious diseases and higher adoption of advanced technologies. Medical Products companies Abbott Laboratories ABT and Bio-Rad Laboratories BIO are two key players in the U.S. clinical diagnostics market . Let us run a comparative analysis of these two stocks, both carrying a Zacks Rank 3 (Hold). You can see the (Strong Buy) stocks here . Diagnostics is a significant part of IL-based …
ABT or BIO: Which Stock Has Better Potential Right Now? - July 15, 2019 - Zacks.com | 7/15/2019
… diseases, increasing occurrence of infectious diseases and higher adoption of advanced technologies. Medical Products companies Abbott Laboratories ( ABT - Free Report ) and Bio-Rad Laboratories ( BIO - Free Report ) are two key players in the U.S. clinical diagnostics market . Let us run a comparative analysis of these two stocks, both carrying a Zacks Rank 3 (Hold). You can see the complete list of today’s Zacks 1 Rank (Strong Buy) stocks here . Diagnostics …
WordPress.com Clinical Diagnostics Market Study By Diagnostics, Applications & Top Key Players – Siemens Healthcare, Sonic Healthcare Ltd., Charles River Laboratories, Quest Diagnostics Inc., Bioscientia Healthcare, Bio-Reference Laboratories The report enumerates the Clinical Diagnostics Market share held by the major players of the industry and delivers a full view of the competitive landscape. This market is categorized into different segments with the comprehensive analysis of each with respect to the geography …
SQI Diagnostics Reports Second Quarter 2019 Results | PR Newswire | 5/16/2019
… sqidiagnostics.com About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human …
SQI Diagnostics to Announce Second Quarter 2019 Results | PR Newswire | 5/2/2019
… sqidiagnostics.com About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human …
… in the developing countries are few trends witnessed in the automated immunoassay analyzer market. Download PDF to know more details about “ Automated Immunoassay Analyzer Market “ 2023. One of the leading players operating in the clinical diagnostics market , Beckman Coulter recently declared the launching of a fully automated microplate system for blood testing, named PK7400. It will be specially used in plasma centers, blood donor centers, and large reference labs. This …
Siemens
… CAGR, over the forecast period, spearheaded by India . Some key market players include Abbott, F. Hoffmann-La Roche Ltd., Qiagen, Siemens Healthcare Private Limited, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Johnson & Johnson Services … Market Variables, Trends & Scope 3.1. Biomarkers Market Lineage Outlook 3.1.1. Clinical Diagnostics Market Outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Regulatory Framework 3.3.1. Reimbursement Framework 3.3.2. Standards & Compliances 3.4. Market Dynamics 3.4.1. Market Driver Analysis …
WordPress.com Clinical Diagnostics Market Study By Diagnostics, Applications & Top Key Players – Siemens Healthcare, Sonic Healthcare Ltd., Charles River Laboratories, Quest Diagnostics Inc., Bioscientia Healthcare, Bio-Reference Laboratories The report enumerates the Clinical Diagnostics Market share held by the major players of the industry and delivers a full view of the competitive landscape. This market is categorized into different segments with the comprehensive analysis of each with respect to the geography …
Qiagen
… fastest CAGR, over the forecast period, spearheaded by India . Some key market players include Abbott, F. Hoffmann-La Roche Ltd., Qiagen, Siemens Healthcare Private Limited, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Johnson & Johnson … Market Variables, Trends & Scope 3.1. Biomarkers Market Lineage Outlook 3.1.1. Clinical Diagnostics Market Outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Regulatory Framework 3.3.1. Reimbursement Framework 3.3.2. Standards & Compliances 3.4. Market Dynamics 3.4.1. Market Driver Analysis …
… is positioned to witness the fastest CAGR, over the forecast period, spearheaded by India.Some key market players include Abbott, Roche, Qiagen, Siemens Healthcare, Thermo Fisher Scientific, Bio-Rad Laboratories, Johnson & Johnson Services, Agilent Technologies, and … Biomarkers Market Variables, Trends & Scope 3.1. Biomarkers Market Lineage Outlook3.1.1. Clinical Diagnostics Market Outlook3.2. Penetration & Growth Prospect Mapping3.3. Regulatory Framework …
Abbott Laboratories
DUBLIN–(BUSINESS WIRE)–Nov 28, 2019– The “Clinical Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)” report has been added to ResearchAndMarkets.com ‘s offering. The clinical diagnostics market is driven by factors such as the … players. Some of the key players of the market include Abbott Laboratories, bioMerieux, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, Qiagen, Roche Diagnostics, among others. With the rising advances in the clinical …
ABT or BIO: Which Stock Has Better Potential Right Now? - Nasdaq.com | 7/15/2019
… Abbott Laboratories ABT and Bio-Rad Laboratories BIO are two key players in the U.S. clinical diagnostics market. Let us run a comparative analysis of these two stocks, both carrying a Zacks Rank 3 (Hold). You can see the (Strong Buy) stocks here . Diagnostics is a significant part of IL-based Abbott’s business. Its product line comprises a broad range of diagnostic systems and tests manufactured, marketed and sold globally …
Andrew Morris
SQI Diagnostics to Announce Fourth Quarter and Fiscal 2019 Results | PR Newswire | 12/4/2019
… the fourth quarter and year ended September 30, 2019 , at 5:30 p.m. ET Wednesday, December 11 , 2019. President and CEO, Andrew Morris , along with Company management, will host a conference call on Thursday, December 12 … its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics markets. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one …
SQI Diagnostics Reports Third Quarter 2019 Results | PR Newswire | 8/28/2019
… Toronto -based life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced multiplexed diagnostics. Said Andrew Morris , SQI’s President and CEO: “During the last quarter we achieved a significant milestone … its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics markets. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one …
About:
Editor:
